IBD Icons launched
American Idol star Casey Abrams is promoting understanding of crohn’s and Colitis as well as offering a fantatsic prize for the ‘IBD icon’ of the year. Read more here:
Remicade/Infliximab has been FDA Approved for use in children. The FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children. Infliximab, a tumor necrosis factor (TNF) inhibitor, is already approved to treat ulcerative colitis in adults and is also approved to treat Crohn’s disease in both adults and children. Read more here: http://www.medpagetoday.com/Gastroenterology/InflammatoryBowelDisease/27679
Lonza wins contract for bertilimumab(how on earth do you pronounce that?!!!)
Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and manufacturing facility in the UK.
The deal will see the Swiss CMO produce clinical supplies of the antibody in it’s centre in Milton Keynes. Bertilimumab is just about to start a phase II trials programme in inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis.
Bertilimumab is the first monoclonal antibody to specifically neutralise human eotaxin-1, a chemokine associated with inflammatory disease activity.